| What it is |
Brand‑name product that contained naproxen sodium (the same active ingredient). |
The generic drug naproxen sodium (or naproxen acid). |
| Formulation |
Usually 220 mg naproxen sodium tablets (Pfizer, 1990s–2000s). (There were also 500 mg tablets for rheumatology indications.) |
Comes in many forms: 220 mg tablets (OTC – e.g., Aleve®), 250 mg tablets (OTC), 500 mg tablets (prescription), liquid concentrates, etc. |
| Availability |
Discontinued in the U.S. (Pfizer stopped marketing it). Still available in some other countries under different brand names. |
Widely available OTC and prescription worldwide. |
| Indications |
– Pain (musculoskeletal, menstrual). – Osteoarthritis. – Rheumatoid arthritis. – Other acute pain conditions. |
Same: musculoskeletal pain, OA, RA, ankylosing spondylitis, gout, menstrual cramps, post‑operative pain, etc. |
| Dose (typical) |
220 mg PO, 1–2×/day for pain; 500 mg PO, 1–2×/day for inflammatory conditions. |
220 mg PO, 1–2×/day for OTC pain; 250–500 mg PO, 1–2×/day for prescription use. |
| Mechanism |
Non‑steroidal anti‑inflammatory: inhibits COX‑1 & COX‑2 → ↓ prostaglandin synthesis. |
Same mechanism. |
| Pharmacokinetics |
Tmax ~1–1.5 h; half‑life ~12–14 h. |
Identical pharmacokinetics. |
| Side‑effects |
GI upset, ulcers, bleeding, dyspepsia, nausea; cardiovascular (HTN, edema), renal, hepatic, allergic. |
Same profile. |
| Black‑box warning |
Yes – risk of serious GI bleeding, perforation, ulcer, and cardiovascular events. |
Same. |
| Cost |
Used to be higher (brand name); now mainly a historical reference. |
Generic is usually $5–$15 for a 30‑day supply; brand (e.g., Aleve) ~$20–$30. |